We're buying more of a beaten-up stock before another overhang is lifted

Jim Cramer's Charitable Trust is buying 35 Boeing shares at about $191.16, taking its holding to 620 shares and portfolio weighting to 3% from 2.8%. The FAA could approve the 737 Max 10 as soon as this week; certification this month could support customer deliveries in 2027 and reduce uncertainty around a backlog in which reports say about one-third is for the delayed variant. Boeing shares remain about 20% below their Aug. 5 close despite recent positive developments, while elevated oil prices and interest rates are cited as near-term headwinds.

Analysis

The key distinction is between regulatory de-risking and cash-flow realization. Approval would remove one specific obstacle and improve confidence in backlog convertibility, but it would not itself accelerate deliveries or prove Boeing can produce the aircraft at a reliable rate. The reported share of the 737 backlog tied to the MAX 10 should be verified against Boeing disclosures; even if accurate, backlog is not equivalent to near-term revenue or cash.

Over days, an approval could prompt a relief rally, but the event may be partly anticipated and vulnerable to a sell-the-news response. Over 1–3 months, watch whether Boeing translates certification into delivery guidance and whether production and quality metrics remain stable. Over 6–18 months, consistent delivery execution and free-cash-flow improvement matter more than the certificate. Airbus benefits if Boeing’s delays persist; suppliers and airlines may also face schedule and fleet-planning shifts, but the direction depends on actual delivery timing.

The contrarian risk is treating a regulatory milestone as a resolution of Boeing’s broader execution and balance-sheet concerns. Higher rates can raise financing hurdles for airlines and weigh on equity multiples; higher fuel costs may support demand for more efficient aircraft but can also pressure airline economics and defer purchases. The thesis weakens if certification slips, Boeing cuts delivery or cash-flow expectations, or quality/production issues interrupt the ramp.

Key Decisions for Investors

• For a bullish view, consider building BA exposure in stages around the certification event rather than making the full add ahead of a binary decision. Keep sizing modest until delivery guidance and production execution confirm that approval can convert into cash generation.
• Treat FAA approval as a short-term catalyst, not a standalone fundamental re-rating signal. Reassess after Boeing provides evidence on delivery timing, production rates, and free cash flow; do not extrapolate the reported backlog mix into near-term earnings.
• Falsification/watch list: certification is delayed beyond the stated window; Boeing revises delivery or free-cash-flow expectations lower; or quality and production disruptions return. Any of these would outweigh the value of the approval milestone.
• Airbus is the relative beneficiary if MAX 10 uncertainty persists, but avoid a simple BA-versus-Airbus pair solely on this headline: the competitive impact depends on airline order substitution and delivery slots, neither of which is established here.